RHBC
ZBH icon

R.H. Bluestein & Co’s Zimmer Biomet ZBH Stock Holding History

R.H. Bluestein & Co’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,442
Closed -$205K – 425
2021
Q3 		$205K Sell
1,442
-1,039
-42% -$153K 0.01% 401
2021
Q2 		$387K Buy
2,481
+421
+20% +$68.2K 0.02% 272
2021
Q1 		$320K Hold
2,060
– – 0.01% 294
2020
Q4 		$308K Hold
2,060
– – 0.01% 276
2020
Q3 		$272K Hold
2,060
– – 0.01% 266
2020
Q2 		$239K Hold
2,060
– – 0.01% 283
2020
Q1 		$202K Sell
2,060
-824
-29% -$108K 0.02% 259
2019
Q4 		$419K Buy
+2,884
New +$398K 0.02% 191

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

R.H. Bluestein & Co's ZBH Position: Q4 2021 in Review

R.H. Bluestein & Co sold out of Zimmer Biomet (ZBH) in Q4 2021, closing a stake of 1,442 shares — an estimated $205K sold.

R.H. Bluestein & Co first reported a position in ZBH in Q4 2019 and held it in 8 quarters. The position peaked at $419K in Q4 2019. 998 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.

  • R.H. Bluestein & Co reported no remaining Zimmer Biomet position as of Q4 2021 after selling out during the quarter.
  • R.H. Bluestein & Co sold 1,442 Zimmer Biomet shares in Q4 2021, an estimated $205K.
  • R.H. Bluestein & Co first reported a position in Zimmer Biomet in Q4 2019 and held it in 8 quarters.
  • R.H. Bluestein & Co's Zimmer Biomet position peaked at $419K in Q4 2019.
  • 998 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.

Based on R.H. Bluestein & Co's 13F filing for Q4 2021, filed 14 Feb 2022.